Topics

STAAR Surgical Reports First Quarter Results

16:01 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
ICL Units Up 39% Resulting in Seventh Consecutive Quarter of Significant Growth Earnings per Share of $0.03 Announces U.S. Surgeons Summit STAAR Surgical Company (NASDAQ: STAA), a leading developer, ...

Other Sources for this Article

Investors & Media
Brian Moore
Sr. Director, Investor, Media Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com

NEXT ARTICLE

More From BioPortfolio on "STAAR Surgical Reports First Quarter Results"

Quick Search

Relevant Topics

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...